These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 7505029

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Investigations in the use of mogramostime (GM-CSF) in patients with acute leukemia].
    Paśnicki M.
    Wiad Lek; 1995; 48(1-12):194-7. PubMed ID: 9638239
    [No Abstract] [Full Text] [Related]

  • 3. Effects of recombinant granulocyte colony-stimulating factor (G-CSF) in patients treated with ProMACE-CytaBOM for HIV-related non-Hodgkin's lymphoma (NHL).
    Rossi G, Donisi A, Casari S, Re A, Stellini R, Cadeo G, Carosi G.
    Haematologica; 1998 Apr; 83(4):317-22. PubMed ID: 9592981
    [Abstract] [Full Text] [Related]

  • 4. DNA as a carrier for anthracyclines in the treatment of acute myelocytic leukemia (AML).
    Gahrton G, Tidefelt U, Paul C, Björkholm M, Grimfors G, Hast R, Juliusson G, Järnmark M, Killander A, Kimby E.
    Leukemia; 1992 Apr; 6 Suppl 2():89-91. PubMed ID: 1578953
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of acute non-lymphocytic leukemia with alternating non-cross resistant chemotherapy.
    Kyo T, Dohy H.
    Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1641-52. PubMed ID: 3247827
    [No Abstract] [Full Text] [Related]

  • 6. Results of aggressive chemotherapy for myelodysplastic syndromes.
    Dohy H, Kyo T.
    Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1428-34. PubMed ID: 3247817
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of acute nonlymphocytic leukemia by combination of recombinant human granulocyte colony-stimulating factor and cytotoxic agents: a report of six cases.
    Hanazono Y, Miyazono K, Piao YF, Taketazu F, Chiba S, Miyagawa K, Hirai H, Sakamoto S, Miura Y, Yazaki Y.
    Int J Hematol; 1992 Jun; 55(3):243-8. PubMed ID: 1379844
    [Abstract] [Full Text] [Related]

  • 8. Granulocyte colony stimulating factor (G-CSF) as adjunct therapy in relapsed-resistant high-grade non-Hodgkin's lymphoma.
    Zinzani PL, Martelli M, Tura S, Mandelli F.
    Haematologica; 1993 Jun; 78(1):40-3. PubMed ID: 7684011
    [Abstract] [Full Text] [Related]

  • 9. Acute myeloid leukemia in adults: experience at AIIMS.
    Raina V, Kochupillai V.
    J Assoc Physicians India; 1983 Aug; 31(8):511-4. PubMed ID: 6581155
    [No Abstract] [Full Text] [Related]

  • 10. Serial changes of the serum macrophage colony-stimulating factor level after cytoreductive chemotherapy.
    Kimura F, Takemura Y, Ohtsuki T, Mizukami H, Takagi S, Yamamoto K, Nagata N, Motoyoshi K.
    Int J Hematol; 1992 Apr; 55(2):147-55. PubMed ID: 1511164
    [Abstract] [Full Text] [Related]

  • 11. [Kinetics of circulating hematopoietic stem cells following chemotherapy in patients with hematopoietic malignancies].
    Tamura K, Kosaka M, Mizuguchi T, Miyamoto Y.
    Rinsho Ketsueki; 1990 May; 31(5):647-54. PubMed ID: 1697629
    [Abstract] [Full Text] [Related]

  • 12. Association between the secondary colony-plating efficiency of blast progenitors and the remission induction outcome of acute myeloblastic leukemia patients.
    Nara N.
    Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1624-9. PubMed ID: 3247826
    [No Abstract] [Full Text] [Related]

  • 13. [Treatment of leukemia: discussion].
    Nihon Naika Gakkai Zasshi; 1992 Jul 10; 81(7):1081-93. PubMed ID: 1383368
    [No Abstract] [Full Text] [Related]

  • 14. [Hematologic tumors].
    Ogawa M.
    Gan To Kagaku Ryoho; 2003 Oct 10; 30(10):1416-21. PubMed ID: 14584273
    [Abstract] [Full Text] [Related]

  • 15. Granulocyte colony-stimulating factor (G-CSF) prevents dose-limiting neutropenia in lymphoma patients receiving standard dose chemotherapy.
    Dotti G, Stella CC, Mangoni L, Cottafavi L, Caramatti C, Almici C, Rizzoli V.
    Haematologica; 1995 Oct 10; 80(2):142-5. PubMed ID: 7543069
    [Abstract] [Full Text] [Related]

  • 16. [A case of refractory acute myeloblastic leukemia who achieved partial remission by high dose cytosine arabinoside].
    Okamoto S, Ogata H, Yoshida T, Oheda Y, Murase T, Toyama K.
    Rinsho Ketsueki; 1984 May 10; 25(5):719-23. PubMed ID: 6590900
    [No Abstract] [Full Text] [Related]

  • 17. [Complete remission during administration of rhG-CSF in acute myeloblastic leukemia with pneumonia].
    Hayatsu K, Nagai K, Abe A, Murakawa E, Sekiya M.
    Rinsho Ketsueki; 1994 Jan 10; 35(1):59-64. PubMed ID: 7511179
    [Abstract] [Full Text] [Related]

  • 18. [Treatment of acute adult myeloblastic leukemia with intensive chemotherapy].
    Sayas MJ, Sanz MA, Martín-Aragonés G, Javier Rafecas F, Martínez JA, Lorenzo IJ, Sanz GF, Gomis F, Marty ML.
    Sangre (Barc); 1986 Jan 10; 31(6):718-29. PubMed ID: 3470955
    [No Abstract] [Full Text] [Related]

  • 19. [New therapy of patients with malignant lymphoma using G-CSF].
    Asano S.
    Nihon Naika Gakkai Zasshi; 1994 Jun 10; 83(6):924-7. PubMed ID: 7525813
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical significance of recombinant human granulocyte colony-stimulating factor (rG-CSF) in the chemotherapy of patients with malignant lymphoma].
    Kuzuyama Y, Sonoda Y, Okuda T, Takashima T, Misawa S, Kashima K, Nakagawa H, Fujii H, Abe T.
    Rinsho Ketsueki; 1992 Dec 10; 33(12):1789-96. PubMed ID: 1282572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.